ISSN: 1872-3128

Journal Home

Journal Guideline

Drug Metabolism Letters Q3 Unclaimed

Bentham Science Publishers United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Metabolism Letters is a journal indexed in SJR in Biochemistry (medical) and Pharmaceutical Science with an H index of 31. It has an SJR impact factor of 0,175 and it has a best quartile of Q3. It has an SJR impact factor of 0,175.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q3) Biochemistry (medical) (Q4) Clinical Biochemistry (Q4) Pharmacology (medical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,175

SJR Impact factor

31

H Index

0

Total Docs (Last Year)

24

Total Docs (3 years)

0

Total Refs

25

Total Cites (3 years)

23

Citable Docs (3 years)

1.04

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Hormone and Metabolic Research Q3
Biomarkers in Medicine Q3
Journal of International Medical Research Q3
Reports of Biochemistry and Molecular Biology Q3
Molecular Cytogenetics Q3

Compare this journals

Aims and Scope

Best articles by citations

Meet Our Editorial Board Member

Simultaneous Quantitative Determinations of Fluticasone Propionate and Salmeterol Xinafote in Diskus Inhalers

New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery

Disposition and Mass Balance of [14C]Vernakalant After Single Intravenous and Oral Doses in Healthy Volunteers

Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population

Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes

Toxicophoric and Metabolic In Silico Evaluation of Benzimidazole and Phenylbenzamide Derivatives with Potential Application as Anticancer Agents

Unequal Absorption of Radiolabeled and Nonradiolabeled Drug from the Oral Dose Leads to Incorrect Estimates of Drug Absorption and Circulating Metabolites in a Mass Balance Study

The Effects of Obesity on Drug Metabolism in Children

Inhibition of Hepatobiliary Transporters by A Novel Kinase Inhibitor Contributes to Hepatotoxicity in Beagle Dogs

Preface:

A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model

SHOW MORE ARTICLES

Meet Our Editorial Board Member

Divergent Effects of Nitric Oxide Donors on the Biliary Efflux Transporters in Isolated Perfused Rat Livers: Nitric Oxide-Independent Inhibition of ABC Transporters by Sodium Nitroprusside

The Effect of Ethyl Acetate Extract of Pomelo Mix on Systemic Exposure of Verapamil in Rabbits

Application of a Higher Throughput Approach to Derive Apparent Michaelis-Menten Constants of Isoform-Selective P450-Mediated Biotransformation Reactions in Human Hepatocytes

Effect of Oxidative Stress on the Pharmacokinetics of Clomipramine in Rats Treated with Ferric-Nitrilotriacetate

A Comparative Study of the CYP450 Inhibition Potential of Marketed Drugs Using Two Fluorescence Based Assay Platforms Routinely Used in the Pharmaceutical Industry

Alpha-1-Adrenergic Receptor Blockade Modifies Insulin-Regulated Aminopeptidase (IRAP) Activity in Rat Prostate and Modulates Oxytocin Functions

Inhibition and Structural Changes of Liver Alkaline Phosphatase by Tramadol

Co-Induction of CYP3A12 and 3A26 in Dog Liver Slices by Xenobiotics: Species Difference Between Human and Dog CYP3A Induction

Human Liver Enzymes Responsible for Metabolic Elimination of Tyramine, a Vasopressor Agent from Daily Food

Structure-Activity Relationship (SAR): Effort Towards Blocking NGlucuronidation of Indazoles (PF-03376056) By Human UGT1A Enzymes

Statin Drugs, Metabolic Pathways, and Asthma: A Therapeutic Opportunity Needing Further Research